Johnson & Johnson (JNJ: NYSE)
$100.93 -0.2 | -0.2%
05/28/15 - 12:27 PM ET
|Price and Volume|
|52 Week High||109.49|
|52 Week Low||95.10|
|Avg. Daily Vol. (Mil)||7.82|
|Beta (3 year)||0.96|
|Share Related Items|
|Mkt Cap (Mil)||280,438.08|
|Shares Out (Mil)||2,773.05|
|LT Debt/ Equity||0.22|
|Total Debt / Equity||0.28|
|Per Share Data|
|Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale ofproducts in the health care field within its Consumer, Pharmaceutical and Medical Devices, and Diagnostics business segments.|
|One Johnson & Johnson Plaza
New Brunswick, NJ 08933
|Industry : Drugs|
|Sector: Health Care|
|CEO: Alex Gorsky|
|Current Month (Mil)||31.27|
|Previous Month (Mil)||30.08|
|Short Interest Ratio (Days)||4.30|
|Return on Equity||23.40|
|Return on Assets||12.40|
|Return on Investments||19.20|
Portfolios with JNJ
- Portfolio NameUser Type
- ProJohn Hussman - Hussman Stra...
- ProKen Fisher - Fisher Investm...
- ProJoel Greenblatt - Gotham Ca...
- ProJames Barrow - Barrow Hanle...
- ProDonald Yacktman - Yacktman ...
- ProBrian Rogers - T. Rowe Pric...
- ProPrem Watsa - Fairfax Financ...
- ProAdage Capital
- ProAcropolis Investment Manage...
- ContributorRocket Stocks for the Week ...
Latest JNJ Headlines from TheStreet
- 3 High-Yield, Low-Risk Dividend Stocks for Extreme Safety 05.27.15 | 12:05 pm
- 3 Big Pharmaceutical Stocks to Buy Right Now 05.21.15 | 08:05 am
- Will Johnson & Johnson (JNJ) Stock be Helped by New Drug Lineup Plan? 05.20.15 | 09:05 am
- Johnson & Johnson Headed Even Higher After Big-Volume Lift 05.19.15 | 08:05 am
- Urban Outfitters, Target, Wal-Mart Report Earnings This Week With Retail Stocks in the Spotlight 05.18.15 | 07:05 am
- Jim Cramer -- Buy Eaton and These Others to Profit During Market's Sea Change 05.04.15 | 02:05 pm
- Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick 04.27.15 | 12:04 pm
- Today's Top Performers In Drugs 04.24.15 | 01:04 pm
- 15 'Sustainable' Companies Not Named Apple to Buy Right Now 04.22.15 | 04:04 pm
- 3 Stocks Pushing The Drugs Industry Higher 04.20.15 | 01:04 pm
Press Releases for JNJ
- Johnson & Johnson Announces Acceptance Of Binding Offer From Cardinal Health To Acquire Cordis - PR Newswire 05.28.15 | 08:05 am
- Johnson & Johnson To Participate In The Goldman Sachs 36th Annual Global Healthcare Conference - PR Newswire 05.27.15 | 09:05 am
- China Diabetes Management Devices Market Growth To Be Driven By Rise In Sedentary Lifestyle And Life Expectancy And Patient Compliant Technologies Especially For Insulin Pump And CGM - PR Newswire 05.20.15 | 10:05 am
- Johnson & Johnson Pharmaceutical Segment To Continue Driving Above-Industry Growth With Plans To File More Than 10 New Products By 2019, Each With Potential To Exceed $1 Billion In Revenue - PR Newswire 05.20.15 | 07:05 am
- Johnson & Johnson Announces NYU School Of Medicine Partnership To Evaluate Compassionate Use Of Investigational Medicines - PR Newswire 05.07.15 | 12:05 am
- Johnson & Johnson To Participate In The 2015 Deutsche Bank 40th Annual Health Care Conference - PR Newswire 04.30.15 | 09:04 am
- Johnson & Johnson Announces Further Patent And Trademark Office Action Related To REMICADE® - PR Newswire 04.29.15 | 04:04 pm
- India Joint Replacement Market To Grow In Double Digits Through 2020 - PR Newswire 04.27.15 | 12:04 pm
- Johnson & Johnson Announces Dividend Increase Of 7.1% - PR Newswire 04.23.15 | 10:04 am
- Johnson & Johnson To Host Pharmaceutical Business Review - PR Newswire 04.20.15 | 02:04 pm
Partner Headlines for JNJ
- Pfizer and AstraZeneca: one year after deal that never was - Financial Times 05.26.15 | 07:05 pm
- The Zacks Analyst Blog Highlights: Johnson & Johnson, AstraZeneca, ACADIA Pharmaceuticals, Actavis and Alkermes - Press Releases - Zacks 05.26.15 | 09:05 am
- Condom company in sticky situation over lube deal - CNBC 05.22.15 | 08:05 am
- J&J Pays Millions to Settle Billion-Dollar Risperdal Case - Bloomberg 05.21.15 | 03:05 pm
- Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 21, 2015 - NASDAQ 05.20.15 | 01:05 pm
- CNBC Exclusive: CNBC Transcript: Johnson & Johnson Chairman & CEO Alex Gorsky Speaks with CNBC's Meg Tirrell on "Squawk Box" Today - CNBC 05.20.15 | 11:05 am
- J&J: 10 new drugs by 2019, each with $1B potential - CNBC 05.20.15 | 09:05 am
- Achillion price target lowered to $16 from $25 at Leerink - The Fly 05.20.15 | 08:05 am
- Achillion shares remain undervalued after HCV pact with J&J, says Cowen - The Fly 05.20.15 | 07:05 am
- J&J Invests in Alzheimer's, Cancer as Competitive Threats Emerge - Bloomberg 05.20.15 | 07:05 am